| GSE86982 | GSM2317712 | Illumina HiSeq 2500 | Homo sapiens | 54Dn1SK_E09_smart-seq | cultured embryonic stem cells[DCX-][RM165051][viral_barcoded] | days in culture: 54; cre line: DCX-; differentiation#: RM165051; control: FALSE; viral barcoded: viral_barcoded |
| GSE86982 | GSM2317968 | Illumina HiSeq 2500 | Homo sapiens | 54Dp5_E07_smart-seq | cultured embryonic stem cells[DCX+][RM165048] | days in culture: 54; cre line: DCX+; differentiation#: RM165048; control: FALSE |
| GSE86982 | GSM2318224 | Illumina HiSeq 2500 | Homo sapiens | SK_2_D04_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
| GSE52529 | GSM1269027 | Illumina HiSeq 2500 | Homo sapiens | Cell T0_CT_F08 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 0; debris: FALSE; control well: FALSE; cells in well: 0; library protocol: Single-cell |
| GSE57872 | GSM1395412 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH26_B02 | glioblastoma [Pro] | patient id: MGH26; cell type: Glioblastoma; subtype: Pro |
| GSE57872 | GSM1395668 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH28_G06 | glioblastoma [Mes] | patient id: MGH28; cell type: Glioblastoma; subtype: Mes |
| GSE57872 | GSM1395924 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH31_D10 | glioblastoma [None] | patient id: MGH31; cell type: Glioblastoma; subtype: None |
| GSE57872 | GSM1396180 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_B02 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
| GSE64016 | GSM1562508 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp2.135 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
| GSE64016 | GSM1562773 | Illumina HiSeq 2500 | Homo sapiens | S_Exp1.075 | single H1-Fucci cell sorted from S phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
